C.DIFFICILE TOXIN, A & B & GDH STOOL

C. Difficile Toxin A, B & GDH Stool Test is an advanced microbiology test used to detect Clostridioides difficile (C. difficile) infection in stool samples. The test identifies Glutamate Dehydrogenase (GDH) antigen and the toxins A and B produced by the bacteria, helping healthcare providers accurately diagnose C. difficile-associated diarrhea and colitis.

C. difficile infection commonly occurs after antibiotic use and may cause symptoms ranging from mild diarrhea to severe inflammation of the colon. Early diagnosis is important to initiate appropriate treatment, prevent complications, and reduce the spread of infection.

Benefits of the Test

• Detects C. difficile infection accurately.
• Identifies both toxin A and toxin B.
• Includes GDH antigen screening for improved diagnostic accuracy.
• Supports early diagnosis of antibiotic-associated diarrhea.
• Helps diagnose infectious colitis.
• Assists physicians in treatment planning.
• Provides reliable stool infection assessment.
• Supports infection control measures.

Why Doctors Recommend This Test

Doctors recommend this test for patients experiencing persistent diarrhea, abdominal pain, fever, or gastrointestinal symptoms following antibiotic therapy. It is also commonly requested for hospitalized patients and individuals suspected of having Clostridioides difficile infection.

The test helps differentiate C. difficile-related diarrhea from other gastrointestinal conditions and supports appropriate treatment decisions.

Preparation Before Test

• No fasting is required.
• Collect a fresh stool sample in a clean container.
• Avoid contaminating the specimen with urine or water.
• Follow laboratory instructions carefully.
• Inform the doctor about recent antibiotic use.
• Submit the sample promptly to the laboratory.

Normal Reporting Time

Most C. Difficile Toxin A, B & GDH Stool reports at Focus Diagnostics are available within 2–3 hours after specimen processing and laboratory analysis.

Who Should Take This Test?

This test may be recommended for:

• Patients with persistent diarrhea.
• Individuals with recent antibiotic use.
• Hospitalized patients with gastrointestinal symptoms.
• People with suspected infectious colitis.
• Patients experiencing abdominal pain and fever.
• Individuals with recurrent diarrhea.
• Patients undergoing gastrointestinal infection evaluation.
• People at risk of C. difficile infection.

Detailed Information

Clostridioides difficile is a bacterium that can cause significant gastrointestinal disease, particularly after the use of broad-spectrum antibiotics. Antibiotic treatment may disrupt normal intestinal flora, allowing C. difficile to proliferate and produce toxins that damage the lining of the colon. This can result in symptoms ranging from mild diarrhea to severe colitis and life-threatening complications.

The C. difficile Toxin A, B & GDH Stool Test combines multiple diagnostic markers to improve detection accuracy. GDH is an enzyme produced by both toxigenic and non-toxigenic strains of C. difficile and serves as a sensitive screening marker. Toxin A and Toxin B are responsible for the clinical manifestations of infection and their detection provides evidence of active toxin-producing disease.

By evaluating both GDH antigen and toxins, the test offers a comprehensive approach to diagnosing C. difficile infection. This combination helps healthcare providers distinguish between colonization and active disease while reducing the likelihood of false-negative results.

The test is especially useful for patients with antibiotic-associated diarrhea, prolonged hospitalization, immunocompromised status, inflammatory bowel disease, or recurrent gastrointestinal symptoms. Early diagnosis allows prompt treatment, infection control interventions, and prevention of disease transmission.

Accurate identification of C. difficile infection is important because untreated disease may progress to severe colitis, toxic megacolon, dehydration, and other serious complications. Timely diagnosis improves patient outcomes and supports appropriate antimicrobial stewardship.

At Focus Diagnostics, C. Difficile Toxin A, B & GDH Stool testing is performed using advanced laboratory methods, stringent quality control standards, and experienced microbiology professionals to ensure reliable, accurate, and clinically meaningful diagnostic results.